MAXCYTE INC. - COMMON
3.8800
08-10月-24 14:59:58
15 分の遅延
株式
+0.1000
+2.65%
本日の幅
3.7500 - 3.8900
ISIN
N/A
ソース
NASDAQ
-
MaxCyte to Participate in Two Upcoming Investor Conferences
06 11 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
04 10 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
06 9 2023 07:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Baird Global Healthcare Conference
05 9 2023 07:05:00 提供 Nasdaq GlobeNewswire
-
09 8 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
01 8 2023 07:05:51 提供 Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023
13 7 2023 07:05:00 提供 Nasdaq GlobeNewswire
-
10 7 2023 07:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with Lyell Immunopharma
06 7 2023 07:05:05 提供 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
01 6 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Guidance
10 5 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
04 5 2023 07:05:53 提供 Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2023 Financial Results on May 10, 2023
12 4 2023 15:05:30 提供 Nasdaq GlobeNewswire
-
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
27 3 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results
15 3 2023 15:05:23 提供 Nasdaq GlobeNewswire
-
08 3 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
06 3 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
01 2 2023 15:05:53 提供 Nasdaq GlobeNewswire
-
03 1 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
05 12 2022 01:00:00 提供 Nasdaq GlobeNewswire